Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does botulinum toxin A reduce adductor muscle spasticity in children with cerebral palsy?

Nature Clinical Practice Neurology volume 2, pages 414–415 (2006)Cite this article

boxed-textMall V et al. (2006) Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 48: 10–13

When managing adductor spasticity in children with cerebral palsy, botulinum toxin A can be used to increase the passive hip range of motion and to decrease clinically significant spasticity

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Carpenter EB and Seitz DG (1980) Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 22: 497–501

    Article  CAS  Google Scholar 

  2. Koman LA et al. (1993) Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 13: 489–495

    Article  CAS  Google Scholar 

  3. Boyd RN et al. (2001) The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial. Eur J Neurol 8 (Suppl 5): 109–119

    Article  Google Scholar 

  4. Koman LA et al. (2003) Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs 5: 11–23

    Article  Google Scholar 

  5. Pidcock FS et al. (2005) Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A. Arch Phys Med Rehabil 86: 431–435

    Article  Google Scholar 

  6. Willenborg MJ et al. (2002) Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J Pediatr Orthop 22: 165–168

    PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor at the Department of Orthopaedic Surgery, Wake Forest University Health Sciences, Winston-Salem, NC, USA

    L Andrew Koman

Authors
  1. L Andrew Koman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received research support and an honorarium from Allergan; he has also received research support from Solstice Neurosciences, and he is the medical director of SciMed, an LLC that licensed Wake Forest's intellectual property on botulinum toxin products.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koman, L. Does botulinum toxin A reduce adductor muscle spasticity in children with cerebral palsy?. Nat Rev Neurol 2, 414–415 (2006). https://doi.org/10.1038/ncpneuro0244

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0244

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing